| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |